Posted in | News | Gold | Silver | Mining Business

Chesapeake Gold Assigns Royalty Interest on Mexican Metates Gold-Silver Property to Wheaton

Chesapeake Gold Corp. is pleased to announce that it has entered into an agreement whereby Chesapeake has assigned its interest in the 1.5% net smelter returns royalty on its Mexican Metates gold-silver property to Wheaton Precious Metals (Cayman) Co., a subsidiary of Silver Wheaton Corp., in consideration for US$9.0 million.

The Royalty had previously been acquired by Chesapeake for US$9.0 million from SANLUIS Corporation, a private Mexican company (see news release dated May 9, 2014).

As part of the Agreement, Chesapeake will have the right at any time for a period of five years to repurchase two-thirds of the Royalty (that being a 1% net smelter returns royalty) from Wheaton for US$9.0 million with Wheaton continuing to hold a 0.5% Royalty interest. Also as part of the transaction, Chesapeake through its wholly-owned Mexican subsidiary, American Gold Metates, S. de R.C. de C.V. ("AGM") will hold a right of first refusal to purchase the Royalty in the event Wheaton elects to sell the Royalty to a third party, on the same terms and conditions as the third party offer. The Agreement also contains customary terms and conditions for a royalty transaction.

Chesapeake and AGM have also entered into a right of first refusal agreement with Wheaton whereby Chesapeake and AGM have granted Wheaton a right of first refusal on any future silver stream or royalty for which Chesapeake or AGM receives and accepts an offer to purchase, on the same terms and conditions as the third party offer.

P. Randy Reifel, President, commented, "The royalty financing with Wheaton further strengthens our cash position without dilution to our shareholders. The arrangement also provides Chesapeake with leverage and optionality in Metates future development as the project is advanced to the full feasibility stage and beyond."

Currently, Chesapeake is focused on completing an updated pre-feasibility study ("PFS") based on an initial 30,000 tpd ore throughput rate with one or more staged expansions to increase the rate up to 90,000 tpd and/or 120,000 tpd. Evaluations are well advanced to develop a mine plan that would incur a significantly lower initial capital cost and continue to realize the full economic benefit of mining the world class gold-silver reserve at Metates.

Recent investigations have identified several alternate process plant sites near existing infrastructure and limestone resources closer to the Metates mine site. Once the optimum site has been determined, geotechnical investigations, site layout and civil engineering related work will be undertaken in support of the PFS.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chesapeake gold corp.. (2019, February 17). Chesapeake Gold Assigns Royalty Interest on Mexican Metates Gold-Silver Property to Wheaton. AZoMining. Retrieved on July 21, 2024 from https://www.azomining.com/News.aspx?newsID=10295.

  • MLA

    Chesapeake gold corp.. "Chesapeake Gold Assigns Royalty Interest on Mexican Metates Gold-Silver Property to Wheaton". AZoMining. 21 July 2024. <https://www.azomining.com/News.aspx?newsID=10295>.

  • Chicago

    Chesapeake gold corp.. "Chesapeake Gold Assigns Royalty Interest on Mexican Metates Gold-Silver Property to Wheaton". AZoMining. https://www.azomining.com/News.aspx?newsID=10295. (accessed July 21, 2024).

  • Harvard

    Chesapeake gold corp.. 2019. Chesapeake Gold Assigns Royalty Interest on Mexican Metates Gold-Silver Property to Wheaton. AZoMining, viewed 21 July 2024, https://www.azomining.com/News.aspx?newsID=10295.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.